Stocks Up as Bullar...
Health Care: Drugs
Sunesis Pharmaceuticals Inc (SNSS: NASDAQ)
$5.61 0.09 | 1.63%
05/21/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -43.95M | -20.14M | -24.59M | -40.23M |
| Operating Gains/Losses | -93.00K | 211.00K | -145.20K | 56.19K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -580.00K | 242.00K | 55.50K | -430.25K |
| (Decrease) Increase In Other Current Liabilities | 3.79M | 1.57M | 1.32M | -1.34M |
| (Increase) Decrease In Other Working Capital | 19.62M | 0.00 | 15.38K | 74.53K |
| Other Non-Cash Items | 10.23M | -4.49M | 4.51M | 20.98M |
| Net Cash From Continuing Operations | -10.64M | -22.84M | -19.38M | -20.18M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -10.64M | -22.84M | -19.38M | -20.18M |
| Sale of Property, Plant & Equipment | 11.00K | 34.00K | 104.26K | 391.17K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 46.23M | 0.00 | 7.51M | 4.82M |
| Purchases of Property, Plant & Equipment | 0.00 | -15.00K | -64.19K | -6.14K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -67.61M | -52.08M | -46.64M | -503.11K |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -21.37M | 4.18M | -39.08M | 4.70M |
| Issuance of Debt | 14.98M | 9.62M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 22.66M | 4.12M | 68.43M | 13.45M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 37.64M | 13.75M | 68.43M | 13.45M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 5.63M | -4.91M | 9.96M | -2.04M |
Portfolios with SNSS
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserGopher Gold
- ContributorStocks Under-$10 Setting Up...
Latest SNSS Headlines from TheStreet
- Sunesis To Present At Upcoming Investor Conferences 05.10.13 | 03:05 pm
- Sunesis Pharmaceuticals Reports First Quarter Financial Results And Recent Highlights 05.09.13 | 07:05 am
- Sunesis To Host Conference Call On May 9th To Discuss First Quarter Financial Results And Recent Highlights 05.02.13 | 07:05 am
- Sunesis To Present At The Needham & Company 12th Annual Healthcare Conference 04.24.13 | 07:04 am
- Sunesis Pharmaceuticals Reports Fourth Quarter And Full-Year 2012 Financial Results And Recent Highlights 03.13.13 | 07:03 am
- Sunesis To Present At The 25th Annual Roth Conference 03.11.13 | 07:03 am
- Sunesis To Host Conference Call On March 13th To Discuss Fourth Quarter And Full-Year 2012 Financial Results And Recent Highlights 03.06.13 | 07:03 am
- Sunesis To Present At Upcoming Investor Conferences 02.20.13 | 07:02 am
- Sunesis To Present At The Leerink Swann 2013 Global Healthcare Conference 02.06.13 | 07:02 am
- 8 Stocks Under $10 Soaring Higher 01.31.13 | 03:01 pm
Press Releases for SNSS
- Over $400 Million Raised By U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings In 2012, Reports Brinson Patrick - PR Newswire 04.08.13 | 08:04 am
Partner Headlines for SNSS
- Upcoming AML Treatments - Which Company Will Fly? - Seeking Alpha 12.03.12 | 09:12 am
- Morning Market Movers - Benzinga 09.11.12 | 09:09 am
- Arena's Lorcaserin PASSES FDA Approval and 2 Stocks that Have Hit 52-Week Highs - Wall St. Cheat Sheet 06.28.12 | 10:06 am
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Benzinga's Microcap Movers for Friday March 30, 2012 - Benzinga 04.01.12 | 09:04 am
- Sunesis and Royalty Pharma Announce $25M Vosaroxin Royalty Agreement - Benzinga 03.29.12 | 04:03 pm
- 16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money - Seeking Alpha 09.16.11 | 05:09 pm
- 6 Speculative Biotech Stocks Smart Money Loves - Seeking Alpha 05.23.11 | 09:05 am
- Cyclin-Dependent Cancer Confab Preview - SeekingAlpha.com 04.17.10 | 04:04 pm
- UPDATE 1-Sunesis to advance cancer drug development, shares rise - Reuters 02.25.10 | 08:02 am
